Showing 7581-7590 of 8836 results for "".
- Amgen To Acquire Otezla® For $13.4 Billion In Cashhttps://practicaldermatology.com/news/amgen-to-acquire-otezla-for-134-billion-in-cash/2460135/Amgen has entered into an agreement with Celgene Corporation in connection with its previously announced merger with Bristol-Myers Squibb Company </
- Blocking LSD1 May Thwart Common Skin Cancer Growthhttps://practicaldermatology.com/news/blocking-lsd1-may-thwart-common-skin-cancer-growth/2460130/The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow. A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania has now identifie
- Why Don't More Derms Use Lab-based Tools to ID Fungal Infections?https://practicaldermatology.com/news/why-dont-more-derms-use-lab-based-tools-to-id-fungal-infections/2460128/Fungal diagnostic preparations can assist the accurate diagnosis of cutaneous fungal infections. A survey from a team at the George Washington University (GW) identifies barriers that prevent their consistent use. The study is published in the
- Scaravoid May Offer A New Approach to Wound Healinghttps://practicaldermatology.com/news/scaravoid-may-offer-a-new-approach-to-wound-healing/2460126/A new foam that is placed in skin wounds to support and optimize the natural healing process may help prevent scarring. With the "Scaravoid" project, Markus Rottmar, PhD and his team at Empa's Biointerfaces lab
- Ortho Derm Gets NDA for IDP-123 Lotion for Acnehttps://practicaldermatology.com/news/ortho-derm-gets-nda-for-idp-123-lotion-for-acne-1/2460121/The U.S. Food and Drug Administration (FDA) has accepted Ortho Dermatologic’s New Drug Application for IDP-123 (tazarotene 0.045%) Lotion or acne with a PDUFA action date of Dec. 22, 2019. If approved, IDP-123 will be the first taza
- Nebraska Gets “SUNucated”https://practicaldermatology.com/news/nebraska-gets-sunucated/2460116/Nebraska is the latest state to recommend that children be allowed to possess and use sunscreen without a doctor’s note at school and at school-sponsored events. “I am thrilled that Nebraska is stepping up to the plate with commonsense information that will now be con
- Has Cellulite Finally Met its Match with BTL’s Emtone?https://practicaldermatology.com/news/has-cellulite-finally-met-its-match-with-btls-emtone/2460114/Drumroll please…BTL is launching Emtone, a device that targets cellulite via thermal monopolar radiofrequency and mechanical targeted pressure energy simultaneously. This combination results in increased production of collagen and elastin&
- Sciton Targets Veins, Skin, and Hair with Clear Suitehttps://practicaldermatology.com/news/sciton-targets-veins-skin-and-hair-with-clear-suite/2460111/Sciton Inc. is launching its Clear Suite family of products. The Clear Suite offerings make the JOULE platform customizable. Utilizing the 1064 Nd:YAG wavelength, the Clear Suite family of products, including ClearV, ClearSilk, and ClearHair, combined with BroadBand Light (BBL), al
- Summer AAD News: Understanding the Dermatologist’s Role in Reducing Skin-related Side Effects from New Cancer Drugshttps://practicaldermatology.com/news/summer-aad-news-understanding-the-dermatologists-role-in-reducing-skin-related-side-effects-from-new-cancer-drugs/2460107/While a new wave of targeted therapies are helping patients fight cancer, they also produce side effects that can affect patients’ hair, skin and nails that can greatly impact patients’ quality of life and threaten their ability to continue treatment. “Approximat
- Summer AAD News: Hyperhidrosis Updatehttps://practicaldermatology.com/news/summer-aad-news-hyperhidrosis-update/2460106/At least 15 million people in the U.S. experience diminished quality of life due to hyperhidrosis, yet half of people with the condition delay treatment for 10 years or more, according to information presented at the 2019 American Academy of Dermatology Summer Meeting in New York City.